UR-144 50mg 50mg | Purity Not Available
Adooq Bioscience
UR-144 is a potent synthetic cannabinoid (CB) which preferentially binds the peripheral CB2 receptor (Ki = 1.8 nM) over the central CB1 receptor (Ki = 150 nM).
More Information Supplier PageUR-144 is a potent synthetic cannabinoid (CB) which preferentially binds the peripheral CB2 receptor (Ki = 1.8 nM) over the central CB1 receptor (Ki = 150 nM).
More Information Supplier PageUR-144 is a potent synthetic cannabinoid (CB) which preferentially binds the peripheral CB2 receptor (Ki = 1.8 nM) over the central CB1 receptor (Ki = 150 nM).
More Information Supplier PageUR-144 is a potent synthetic cannabinoid (CB) which preferentially binds the peripheral CB2 receptor (Ki = 1.8 nM) over the central CB1 receptor (Ki = 150 nM).
More Information Supplier PageUR-144 is a potent synthetic cannabinoid (CB) which preferentially binds the peripheral CB2 receptor (Ki = 1.8 nM) over the central CB1 receptor (Ki = 150 nM).
More Information Supplier PagePKI-402 is a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor.
More Information Supplier PagePKI-402 is a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor.
More Information Supplier PagePKI-402 is a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor.
More Information Supplier PagePKI-402 is a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor.
More Information Supplier PageFadrozole is a nonsteroidal aromatase inhibitor exhibiting a very potent and selective inhibitory effect of the aromatase enzyme system in vivo and estrogen biosynthesis in vivo.
More Information Supplier PageFadrozole is a nonsteroidal aromatase inhibitor exhibiting a very potent and selective inhibitory effect of the aromatase enzyme system in vivo and estrogen biosynthesis in vivo.
More Information Supplier Page